Cardiac positron emission tomography (PET) perfusion images for two representative patients. Both patients had similar demographic characteristics. Neither patient had significant perfusion abnormalities as shown in the figure. Patient A had mild sleep apnea while patient B had severe obstructive sleep apnea. The corrected myocardial flow reserve (MFR) for patient A was normal at 3.24 while for patient B it was severely abnormal at 1.22.

June 15, 2022 — Patients with severe obstructive sleep apnea (OSA) are less able to increase blood flow to the heart when needed, according to a first-of-its-kind PET imaging study presented at the Society of Nuclear Medicine and Molecular Imaging 2022 Annual Meeting. These findings suggest that cardiac PET imaging—which is used to assess blood flow to the heart—may be helpful in identifying OSA patients who are at high risk of heart disease and its complications. 

The association between OSA and cardiovascular disease is well documented. In this study, researchers sought to specifically examine the association between the markers of OSA severity and coronary microvascular disease, which is a precursor to several cardiovascular diseases. 

Three hundred and forty-six patients underwent diagnostic overnight sleep study and cardiac PET imaging. During the sleep study, obstructive features were categorized into three major groups: mild or no OSA, moderate OSA, or severe OSA. Hypoxia (low levels of oxygen in tissues) severity and clinical symptoms of sleepiness were also recorded. Cardiac PET imaging, which measures myocardial blood flow reserve, was performed to identify coronary microvascular disease. Analyses were conducted to compute the odds ratio of abnormal myocardial blood flow reserve for each of the OSA severity categories. 

The frequency of abnormal myocardial blood flow reserve increased with worsening OSA; patients with severe OSA had more than twice the chances of having heart blood flow impairment as those with mild, moderate, or no OSA. There was no association between hypoxia severity or sleepiness and myocardial blood flow reserve. 

“Interestingly, the significant relationship between OSA severity and myocardial blood flow reserve persisted among those with normal heart PET perfusion scans and no prior history of coronary artery disease,” said Ehimen Aneni, MD, MPH, an instructor at the Yale School of Medicine in New Haven, Connecticut. “The findings of this study may begin to explain why people with obstructive sleep apnea develop heart disease, including heart failure.”

He continued, “Future studies should focus on the role of myocardial blood flow reserve in risk stratification and prognosis of OSA, as well as on the impact of OSA-specific therapy on myocardial blood flow reserve.”

For more information: www.snmmi.org

Find more SNMMI22 coverage here

Snoring Poses Greater Cardiac Risk to Women

MRI Used to Demystify Cardiovascular Consequences of Obstructive Sleep Apnea

Evidence Mounts in Support of More Noninvasive Ventilation


Related Content

News | PET-CT

July 25, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET & PET-CT imaging ...

Time July 25, 2024
arrow
News | Radiology Imaging

July 23, 2024 — EMVision, an Australian medical device company focused on the development and commercialization of ...

Time July 23, 2024
arrow
News | PET-CT

July 16, 2024 — A new research paper was published in Oncotarget's Volume 15 on June 20, 2024, titled, “Comparison of ...

Time July 16, 2024
arrow
Feature | SCCT | by Christine Book

June 27, 2024 — The countdown has begun for the Society of Cardiovascular Computed Tomography (SCCT) 19th Annual ...

Time June 27, 2024
arrow
News | Nuclear Imaging

June 20, 2024 — GE HealthCare joined the world’s top medical and academic institutions at the Society of Nuclear ...

Time June 20, 2024
arrow
News | PET Imaging

June 18, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET and PET-CT ...

Time June 18, 2024
arrow
News | PET Imaging

June 14, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET and PET-CT ...

Time June 14, 2024
arrow
News | PET-CT

June 13, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET and PET-CT ...

Time June 13, 2024
arrow
News | Radiology Business

June 12, 2024 — Cathy Sue Cutler, PhD, FSNMMI, chair of the Isotope Research and Production Department at Brookhaven ...

Time June 12, 2024
arrow
News | SPECT-CT

June 11, 2024 — A newly developed radiotracer can generate high quality and readily interpretable images of cardiac ...

Time June 11, 2024
arrow
Subscribe Now